163 related articles for article (PubMed ID: 21311206)
1. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
[TBL] [Abstract][Full Text] [Related]
2. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
Yetiser S; Satar B; Aydin N
Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages.
Shimizu S; Okuda N; Kato N; Rittling SR; Okawa A; Shinomiya K; Muneta T; Denhardt DT; Noda M; Tsuji K; Asou Y
Arthritis Rheum; 2010 May; 62(5):1329-37. PubMed ID: 20155835
[TBL] [Abstract][Full Text] [Related]
5. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
Sanković-Babić S; Sofronić-Milosavljević Lj
Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
[TBL] [Abstract][Full Text] [Related]
6. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.
Sastry KV; Sharma SC; Mann SB; Ganguly NK; Panda NK
Am J Otol; 1999 Mar; 20(2):158-61. PubMed ID: 10100515
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 expression in otitis media.
Maxwell KS; Fitzgerald JE; Burleson JA; Leonard G; Carpenter R; Kreutzer DL
Laryngoscope; 1994 Aug; 104(8 Pt 1):989-95. PubMed ID: 8052085
[TBL] [Abstract][Full Text] [Related]
8. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
[TBL] [Abstract][Full Text] [Related]
9. [The study of TNF-alpha destructive action to the bone in human middle cholesteatoma].
Xue Q; Jin K; Song H
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Jan; 15(1):13-4. PubMed ID: 12541874
[TBL] [Abstract][Full Text] [Related]
10. Does cytokine profiling of aspirate from jaw cysts and tumors have a role in diagnosis?
Kolokythas A; Karas M; Sarna T; Flick W; Miloro M
J Oral Maxillofac Surg; 2012 May; 70(5):1070-80. PubMed ID: 21802820
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytosolic phospholipase A2 on proinflammatory cytokine-induced bone resorptive genes including receptor activator of nuclear factor kappa B ligand in human dental pulp cells.
Kim YS; Min KS; Lee HD; Oh HW; Kim EC
J Endod; 2010 Apr; 36(4):636-41. PubMed ID: 20307736
[TBL] [Abstract][Full Text] [Related]
12. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus.
Wozniacka A; Lesiak A; Boncela J; Smolarczyk K; McCauliffe DP; Sysa-Jedrzejowska A
Br J Dermatol; 2008 Nov; 159(5):1124-30. PubMed ID: 18764842
[TBL] [Abstract][Full Text] [Related]
13. Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis.
Cağatay T; Kiran B; Yurt S; Gülbaran Z; Kosar F; Cağatay P
Respirology; 2005 Jun; 10(3):290-4. PubMed ID: 15955139
[TBL] [Abstract][Full Text] [Related]
14. Expression of proinflammatory cytokines by human mesenchymal stem cells in response to cyclic tensile strain.
Sumanasinghe RD; Pfeiler TW; Monteiro-Riviere NA; Loboa EG
J Cell Physiol; 2009 Apr; 219(1):77-83. PubMed ID: 19089992
[TBL] [Abstract][Full Text] [Related]
15. Involvement of interleukin-1 in middle ear cholesteatoma.
Shiwa M; Kojima H; Kamide Y; Moriyama H
Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
[TBL] [Abstract][Full Text] [Related]
16. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cytokines present in middle ear effusions.
Yellon RF; Leonard G; Marucha PT; Craven R; Carpenter RJ; Lehmann WB; Burleson JA; Kreutzer DL
Laryngoscope; 1991 Feb; 101(2):165-9. PubMed ID: 1992267
[TBL] [Abstract][Full Text] [Related]
18. Bone Damage in Chronic Otitis Media.
Kuczkowski J; Brzoznowski W; Nowicki T
Ear Nose Throat J; 2022 Aug; 101(7):428-429. PubMed ID: 33090898
[TBL] [Abstract][Full Text] [Related]
19. Morphological alterations and elevations in tumor necrosis factor-alpha, interleukin (IL)-1alpha, and IL-6 in mixed glia cultures following exposure to trimethyltin: modulation by proinflammatory cytokine recombinant proteins and neutralizing antibodies.
Harry GJ; Tyler K; d'Hellencourt CL; Tilson HA; Maier WE
Toxicol Appl Pharmacol; 2002 May; 180(3):205-18. PubMed ID: 12009860
[TBL] [Abstract][Full Text] [Related]
20. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
